Katy McLaughlin - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Katy McLaughlin's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Katy McLaughlin
Verified
Senior Editor, McKinsey Quarterly
Los Angeles
Beats
real estate transactions. city planningReal estate development
Content
By Maya Rotman, Katy McLaughlin| Cell & Gene Verified By Maya Rotman and Katy McLaughlin As cell therapies continue to advance and the demand for these treatments grows, the industry faces ongoing challenges in ensuring that production processes deliver safe products with reproducible performance, scalability, and regulatory compliance. Ensuring product safety, demonstrating efficacy, and navigating complex and dynamic regulatory pathways that may lack harmonization consume valuable time and resources.
By Elana Bryan, Devisree Valsakumar, Nwamaka J. Idigo, Marie Warburton, Kimberly Webb, Katy McLaughlin, Christos Spanos, Simone Lenci, Viktoria Major, Christina Ambrosi, Simon Andrews, Tuncay Baubec, Juri Rappsilber, Philipp Voigt| Cell Press Verified Keywordschromatintranscriptionhistone methylationhistone acetylationbivalent domainsembryonic stem cellsdifferentiationPolycombIntroductionHistone modifications are key regulators of transcription and other chromatin-templated processes. Often in combinatorial fashion, histone marks set up chromatin environments that reflect, reinforce, and potentially instruct transcriptional states by directly regulating access to the DNA and by recruiting factors that activate or repress transcription.
By Maya Rotman, Katy McLaughlin| Cell & Gene Verified By Maya Rotman and Katy McLaughlin As cell therapies continue to advance and the demand for these treatments grows, the industry faces ongoing challenges in ensuring that production processes deliver safe products with reproducible performance, scalability, and regulatory compliance. Ensuring product safety, demonstrating efficacy, and navigating complex and dynamic regulatory pathways that may lack harmonization consume valuable time and resources.
Company Info
McKinsey Quarterly
Los Angeles, United States